GlassScriptPhysician profile
Sm Monir Mohar
NPI 1891175626
$5,183.49
in general payments reported to CMS, 2019-2025
20 companies · $199 in 2025
The $199 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $87.83 · 2021: $124 · 2022: $1,323 · 2023: $3,110 · 2024: $339 · 2025: $199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,993 · Food and Beverage: $1,656.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,993.01 |
| Food and Beverage | $1,655.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,419.98 | 2023-2024 | Vanta Adaptivestim, Intellis Adaptivestim |
| Genesys Orthopedics Systems, L.L.C. | $1,028.94 | 2023 | Sacroiliac Joint Fusion System |
| Relievant Medsystems, INC. | $995.03 | 2022-2023 | Intracept |
| Boston Scientific Corporation | $680.70 | 2020-2023 | Wavewriter Alpha Prime 16, Spectra Wavewriter |
| Abbott Laboratories | $298.06 | 2024-2025 | Proclaim, Eterna |
| Spr Therapeutics, INC | $152.15 | 2023-2024 | Sprint Pns System |
| Axonics, INC. | $148.39 | 2022 | |
| Collegium Pharmaceutical, INC. | $78.93 | 2022-2024 | Xtampza |
| Vertos Medical, INC. | $72.39 | 2022 | |
| Almatica Pharma LLC | $62.94 | 2021 | |
| Nevro Corp. | $44.01 | 2024 | Senza |
| Biohaven Pharmaceutical Holding Company LTD. | $39.70 | 2022 | |
| Foundation Fusion Solutions, LLC | $38.78 | 2024 | |
| Scilex Pharmaceuticals INC. | $23.55 | 2025 | |
| Ferring Pharmaceuticals INC. | $21.22 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $20.83 | 2021 | |
| Stryker Corporation | $17.03 | 2023 | Ivas |
| International Rehabilitative Sciences, INC | $14.59 | 2024 | Rs 4i Plus Sequential Stimulator |
| Nalu Medical, INC. | $14.54 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sm Mohar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.